Yunnan Industry is stronger 丨 The biomedical industry has risen!

Yunnan has always been known as the "Treasury of Drugs" and "Hometown of Fragrance"

The types of Chinese medicinal materials account for 51.4% of the total number of the country

The planting area and yield are ranked first in the country

Has a lot of market prospects and potential

Yunnan Shenwei Shipui Pharmaceutical Co., Ltd. Production Workshop

In recent years

In Yunnan Biomedical Industry

In the process of booming

A group of scientific and technological innovation results

From the laboratory to the market

A number of dazzling results

Bigger and stronger biomedical industry

It is an important measure to promote our province's industrial strong provincial strategy

Recently, the General Office of the Yunnan Provincial Party Committee and the General Office of the Yunnan Provincial People's Government issued the "Three -year Action of the Provincial Provincial Provincial Provincial Provincial Provincial Strong Provincial Education (2022-2024)" (referred to as the "Three Years Action"), and issued a notice to request all the provinces in all provinces All departments in the region are carefully implemented in accordance with the actual situation. The three -year operation put forward the overall goal, requiring that by 2024, the operating income of the biomedical industry in the province reached 360 billion yuan and the value -added of 110 billion yuan, becoming a biomedical industry cluster that has an important influence in the country.

Direction of development

Focusing on consolidating the foundation, innovation mechanism, and building an ecology, support resource mining, key technical research, results transformation, building bases, enhancement of parks, cultivating products, promising local companies, attracting leaders, cultivating teams, and building platforms, actively cultivating orientation for facing faces Future pillar industry.

Yunnan Watson Biological has become a key company reporter of domestic biopharmaceuticals dragon boat photography

Three -year goals

By 2024, the operating income of the biomedical industry will reach 360 billion yuan, and the added value will reach 110 billion yuan. The industrial ecology has gradually optimized, the innovation capabilities have been significantly improved, the market entities have continued to grow, and the industrial scale has continued to grow.

Pharmaceutical production flow line

Key task

01

Promote the development of the entire industrial chain of Chinese medicinal materials such as Sanqi

Based on the development of the development of the entire industrial chain as the demonstration, leading the development of the entire industry chain of Yunnan's characteristic Chinese medicinal chains such as Gastrodiac and Dendrobium.

Introduce and cultivate leading enterprises such as Sanqi and other industrial chains, encourage the construction of bases, markets, parks, construction platforms, and channels, and build a full -industry chain development based on raw material bases, leading enterprises, support, and coordinated development of upstream and downstream supporting coordinated development. pattern.

Improve the standard system of green production technology, comprehensively promote the production area, improve the initial processing level of the place of production, and build an organic, green, and GAP (standardized quality management specifications of Chinese medicinal materials) standardized production bases.

Promoting the entire process of the traditional Chinese medicinal market transaction can be traced, and the digital transformation of Wenshan Sanqi Trade Center of the Chinese Medicine Materials of Wenshan Sanqi.

Encourage leading enterprises to jointly build innovative platforms such as key laboratories and engineering research centers to promote the development of innovative chain in the industrial chain.

Support the introduction of strategic collaborators and activate idle drug approval.

Encourage leading enterprises to cooperate with medical institutions to develop medical institutions for traditional Chinese medicine preparations, improve the level of process and product quality, expand the market size, and develop new Chinese medicines based on traditional Chinese medicine preparations of medical institutions.

02

Accelerate the development of the vaccine industry

Strengthen the research and development of new vaccines, break the design of vaccine molecular design, multi -price design, new vaccine agent and other key technologies, promote the development of new vaccines in the fields of major infectious diseases, malignant tumors and other fields, and accelerate the establishment of an open -end research and development system for industry -university -research collaborative innovation. Essence

Fully support the construction of the biological product approval laboratory in our province, with the goal of the international supply of vaccine, and improve the ability of batch issuance.

Support major projects such as research and development and production of new vaccines, new crown MRNA vaccines and 2 -valent HPV vaccine industrialization, and introduce a number of industrial chain projects such as internal packaging materials such as drug glass bottles, pre -irrigation blocks, and special equipment.

13 -valent pneumococcal polysaccharide binding vaccine developed by Yunnan Watson Biotechnology Co., Ltd.

Support Kunming High -tech Industrial Development Zone and Yuxi High -tech Industrial Development Zone and other vaccine industry clusters.

Relying on China (Yunnan) Free Trade Pilot Zone, enterprises are encouraged to build a trade platform and promote the vaccine to "go global".

Focusing on large 13 valence of pneumococcal polysaccharides, 2 -valent HPV vaccine, new crown mRNA vaccine, 4 -valent brain polysaccharide binding vaccine, new crown -dying vaccine, F genotype gonitis reduction vaccine, rotor virus excessive vaccine ( Vero cells), components without cells perbal vaccine, Bai Bai Po+HIB combined vaccine, non -cell thoroughbin -indigenous SABIN strain cord 四 四 四 四 vaccine, frozen dry hepatitis Price such as virus vaccine, reorganization of hepatitis A and B vaccine.

Strive for 2024, the total economic volume of the vaccine industry will reach 50 billion yuan.

03

Cultivate key products

Based on the clinical value of drugs and the use value of health products, it focuses on supporting the development and secondary development of traditional Chinese medicine products such as Yunnan Baiyao Series, Blood Sylon series, bone injury healing series, lantern series, American Dajiu series, and dragon blood exhaustion series.

Support the development of blood products and develop cytokines in accordance with laws and regulations.

Focus on innovative drugs, improved new drugs, generic drugs such as major illnesses and incorporate breakthrough treatment procedures, and develop the treatment of malignant tumor small molecules IDH1 inhibitors, hydrochloric acid hydrochloride ainetate, and amproid hydrochloride hydrochloride oscopycopic elane olighetamine The solution, Luoshi, relying on Kobese, Cefelokan suspension, etc.

Focus on cultivating Gastrodia series, Dendrobium series, yellow essence series, spiral series of health products and efficacy skin care products.

Establish a key tracking mechanism and "face -to -face" docking service mechanism, provide enterprises with normal consulting services, and solve key difficulties in product development.

04

Build an industrial development ecology

Open up the full chain of innovation of the biomedical industry, focus on the advantages of scientific research institutions, colleges and universities, and pharmaceutical companies in the province, with four joint platforms of new drug discovery, patent medicine evaluation, clinical evaluation and technical transfer and industrial incubation.Unit to form an innovative joint force.

Industry chain, creating an innovation system for the Yunnan biomedical industry.

Pharmaceutical Workshop

Collaborative force, the same frequency resonance

Let the "cloud medicine" go from the deep mountains to the world

Let Yunnan Biomedical Industry

Rise in Yunling earth

Plan: Xie Wei Jiang Min

Coordinating: Zhang Haiyan Huang Jialun

Some pictures are information diagrams

Editor: Lu Orange

Beautiful editor: Lin Xianfu

- END -